Scilex (SCLX) announced that the registration statement on Form S-4 related to the previously announced proposed business combination between Denali Capital Acquisition Corp., a special purpose acquisition company, and Semnur Pharmaceuticals, a majority-owned subsidiary of Scilex, has been declared effective by the U.S. SEC.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SCLX: